BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 31376746)

  • 1. Interfacial engineered gadolinium oxide nanoparticles for magnetic resonance imaging guided microenvironment-mediated synergetic chemodynamic/photothermal therapy.
    Zhao Z; Xu K; Fu C; Liu H; Lei M; Bao J; Fu A; Yu Y; Zhang W
    Biomaterials; 2019 Oct; 219():119379. PubMed ID: 31376746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
    Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
    J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
    Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
    Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearable Theranostic Platform with a pH-Independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.
    Chen Q; Luo Y; Du W; Liu Z; Zhang S; Yang J; Yao H; Liu T; Ma M; Chen H
    ACS Appl Mater Interfaces; 2019 May; 11(20):18133-18144. PubMed ID: 31046230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer Cells.
    Miao ZH; Wang H; Yang H; Li ZL; Zhen L; Xu CY
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):16946-52. PubMed ID: 26196160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Specific Endogenous Fe
    Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molybdenum disulfide-based hyaluronic acid-guided multifunctional theranostic nanoplatform for magnetic resonance imaging and synergetic chemo-photothermal therapy.
    Liu J; Zheng J; Nie H; Zhang D; Cao D; Xing Z; Li B; Jia L
    J Colloid Interface Sci; 2019 Jul; 548():131-144. PubMed ID: 30991180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
    Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
    Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
    Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy.
    Hu X; Tang Y; Hu Y; Lu F; Lu X; Wang Y; Li J; Li Y; Ji Y; Wang W; Ye D; Fan Q; Huang W
    Theranostics; 2019; 9(14):4168-4181. PubMed ID: 31281539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy.
    Hu H; Yang Q; Baroni S; Yang H; Aime S; Steinmetz NF
    Nanoscale; 2019 May; 11(19):9760-9768. PubMed ID: 31066418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Gd-doped polydopamine (PDA)-based theranostic nanoplatform as a strong MR/PA dual-modal imaging agent for PTT/PDT synergistic therapy.
    Pu Y; Zhu Y; Qiao Z; Xin N; Chen S; Sun J; Jin R; Nie Y; Fan H
    J Mater Chem B; 2021 Feb; 9(7):1846-1857. PubMed ID: 33527969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Stimuli-Responsive Multifunctional Gd
    Kuang Y; Zhang Y; Zhao Y; Cao Y; Zhang Y; Chong Y; Pei R
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):35928-35939. PubMed ID: 32686939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy.
    Zhang R; Liu M; Liu S; Liang X; Lu R; Shuai X; Wu D; Cao Z
    Acta Biomater; 2023 Dec; 172():454-465. PubMed ID: 37863345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MnCO
    Lee KK; Lee JH; Lee SC; Lee CS
    Theranostics; 2022; 12(15):6762-6778. PubMed ID: 36185599
    [No Abstract]   [Full Text] [Related]  

  • 16. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
    Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
    Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Fe
    Luo K; Zhao J; Jia C; Chen Y; Zhang Z; Zhang J; Huang M; Wang S
    ACS Appl Mater Interfaces; 2020 May; 12(20):22650-22660. PubMed ID: 32330380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
    Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
    J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR-laser-triggered gadolinium-doped carbon dots for magnetic resonance imaging, drug delivery and combined photothermal chemotherapy for triple negative breast cancer.
    Jiang Q; Liu L; Li Q; Cao Y; Chen D; Du Q; Yang X; Huang D; Pei R; Chen X; Huang G
    J Nanobiotechnology; 2021 Mar; 19(1):64. PubMed ID: 33653352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.